12 Annual PEGS Europe Virtual Summit 2020

9 Nov – 12 Nov 2020

Myriam Fabre, PhD. (Oncomatryx R&D Director) will present at the virtual conference, next Tuesday 10th November, in the session included in the section «Next generation ADCs»: Oncomatryx

OMTX705, a novel FAP-targeting ADC demonstrates activity in chemotherapy and pembrolizumab-resistant solid tumor models

She will also participate as a moderator in the Discussion Panel that concludes the session: “Improving the therapeutic index in ADCs”